当前位置:首页 - 行情中心 - 汇宇制药-W(688553) - 财务分析 - 现金流量表

汇宇制药-W

(688553)

  

流通市值:73.72亿  总市值:90.90亿
流通股本:3.44亿   总股本:4.24亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金913,898,156.93576,129,500.01295,333,237.741,169,003,551.67
  收到的税费返还13,021,236.948,318,146.46229,173.3516,557,417.07
  收到其他与经营活动有关的现金104,968,779.2277,654,836.0851,001,923.74105,921,407.02
  经营活动现金流入小计1,031,888,173.09662,102,482.55346,564,334.831,291,482,375.76
  购买商品、接受劳务支付的现金279,761,178.2196,853,160.68102,321,191.67169,507,856.83
  支付给职工以及为职工支付的现金167,827,687.64119,755,694.5169,376,372.82262,619,402.77
  支付的各项税费57,162,814.0337,432,550.417,099,91255,241,446.03
  支付其他与经营活动有关的现金495,968,159.94335,126,793.27155,204,935.33561,158,075.22
  经营活动现金流出的平衡项目000.010
  经营活动现金流出小计1,000,719,839.81689,168,198.86344,002,411.831,048,526,780.85
  经营活动产生的现金流量净额平衡项目000.010
  经营活动产生的现金流量净额31,168,333.28-27,065,716.312,561,923.01242,955,594.91
二、投资活动产生的现金流量:
  收回投资收到的现金580,405,909.78263,000,00040,000,0001,578,000,000
  取得投资收益收到的现金3,005,902.032,703,545.941,100,496.1120,554,005.38
  处置固定资产、无形资产和其他长期资产收回的现金净额83,789.7920,000-98,995
  投资活动现金流入小计583,495,601.6265,723,545.9441,100,496.111,598,653,000.38
  购建固定资产、无形资产和其他长期资产支付的现金82,355,562.1851,722,115.3538,596,312.19128,180,390.42
  投资支付的现金363,000,000233,000,000190,000,0001,200,015,133.84
  投资活动现金流出小计445,355,562.18284,722,115.35228,596,312.191,328,195,524.26
  投资活动产生的现金流量净额138,140,039.42-18,998,569.41-187,495,816.08270,457,476.12
三、筹资活动产生的现金流量:
  取得借款收到的现金390,146,000359,146,000156,100,000385,000,000
  收到其他与筹资活动有关的现金234,925,444.45234,925,444.45173,203,500271,393,025.01
  筹资活动现金流入小计625,071,444.45594,071,444.45329,303,500656,393,025.01
  偿还债务支付的现金365,004,466.67325,000,000270,000,000326,500,000
  分配股利、利润或偿付利息支付的现金194,946,780.04193,157,388.371,885,967.5198,135,971.8
  支付其他与筹资活动有关的现金165,639,900165,639,900115,000,000318,056,546.71
  筹资活动现金流出小计725,591,146.71683,797,288.37386,885,967.51742,692,518.51
  筹资活动产生的现金流量净额-100,519,702.26-89,725,843.92-57,582,467.51-86,299,493.5
四、汇率变动对现金及现金等价物的影响3,909,781.693,959,643.3-66,510.81
  现金及现金等价物净增加额平衡项目0-0.0100
五、现金及现金等价物净增加额72,698,452.13-131,830,486.35-242,516,360.58427,180,088.34
  加:期初现金及现金等价物余额2,057,244,246.522,057,244,246.522,057,244,246.521,630,064,158.18
  期末现金及现金等价物余额平衡项目-0.010-0.010
  期末现金及现金等价物余额2,129,942,698.641,925,413,760.171,814,727,885.932,057,244,246.52
补充资料:
  净利润--83,595,454.15-315,897,222.3
  资产减值准备--102,518.99-14,813,594.43
  固定资产和投资性房地产折旧-44,176,735.62-75,059,899.59
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-44,176,735.62-75,059,899.59
  无形资产摊销-1,113,421.18-2,261,992.82
  长期待摊费用摊销-460,881.84-921,763.68
  处置固定资产、无形资产和其他长期资产的损失-21,342.13-301,236.61
  固定资产报废损失---843,877.22
  公允价值变动损失-146,324,714.95--239,856,212.2
  财务费用-5,248,399.9-13,302,626.07
  投资损失--3,029,759.73--13,815,175.53
  递延所得税--23,488,849.5-30,311,171.84
  其中:递延所得税资产减少--20,563,569.79-29,337,709.28
    递延所得税负债增加--2,925,279.71-973,462.56
  存货的减少--58,215,946.64--12,876,292.81
  经营性应收项目的减少-30,501,313.61--20,265,210.39
  经营性应付项目的增加--88,214,100.98-73,372,590.06
  其他---1,977,617.36
  现金的期末余额-1,925,413,760.17-2,057,244,246.52
  减:现金的期初余额-2,057,244,246.52-1,630,064,158.18
  现金及现金等价物的净增加额--131,830,486.35-427,180,088.34
公告日期2025-10-302025-08-302025-04-262025-04-26
审计意见(境内)标准无保留意见
TOP↑